Home › Medulloblastoma › Massachusetts › Boston
Medulloblastoma clinical trials in Boston, MA
3 studies for Medulloblastoma are looking for participants at sites in and around Boston (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
B7-H3.CD28Z.CART in CNS Neoplasms
RecruitingPhase 1
- Boston Children's Hospital, Boston
- Dana-Farber Cancer Institute, Boston
A Study of Treatment for Medulloblastoma Using Sodium Thiosulfate to Reduce Hearing Loss
RecruitingPhase 3
- Dana-Farber Cancer Institute, Boston
PEP-CMV Vaccine Targeting CMV Antigen to Treat Newly Diagnosed Pediatric HGG and DIPG and Recurrent Medulloblastoma
RecruitingPhase 2
- Dana-Farber Cancer Institute, Boston
Medulloblastoma trials in other cities
- Washington, DC9 studies
- St. Louis, MO6 studies
- Houston, TX4 studies
- New York City, NY4 studies
- Durham, NC4 studies
- Philadelphia, PA4 studies
- Seattle, WA4 studies
- Miami, FL4 studies
- Tampa, FL4 studies
- Memphis, TN3 studies
- Ann Arbor, MI3 studies
- Chicago, IL3 studies
Other studies in Boston
- Breast Cancer111 studies
- Non-Small Cell Lung Cancer90 studies
- Cancer (all types)86 studies
- Colorectal Cancer63 studies
- Metastatic Cancer63 studies
- Lung Cancer62 studies
- Ovarian Cancer61 studies
- Prostate Cancer59 studies
- Depression52 studies
- Endometrial Cancer50 studies
- Heart Failure44 studies
- Acute Myeloid Leukemia44 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.